Abstract:BackgroundIncreased plaque vulnerability and higher lipid variability are causes of adverse cardiovascular events. Despite a close association between glucose and lipid metabolisms, the influence of elevated glycated hemoglobin A1c (HbA1c) on plaque vulnerability and lipid variability remains unclear.MethodsAmong subjects undergoing percutaneous coronary intervention (PCI) from 2009 through 2019, 366 patients received intravascular optical coherence tomography (OCT) assessment and 4,445 patients underwent the scheduled follow-ups within 1 year after PCI. Vulnerability features of culprit vessels were analyzed by OCT examination, including the assessment of lipid, macrophage, calcium, and minimal fibrous cap thickness (FCT). Visit-to-visit lipid variability was determined by different definitions including standard deviation (SD), coefficient of variation (CV), and variability independent of the mean (VIM). Multivariable linear regression analysis was used to verify the influence of HbA1c on plaque vulnerability features and lipid variability. Exploratory analyses were also performed in non-diabetic patients.ResultsAmong enrolled subjects, the pre-procedure HbA1c was 5.90 ± 1.31%, and the average follow-up HbA1c was 5.98 ± 1.16%. By OCT assessment, multivariable linear regression analyses demonstrated that patients with elevated HbA1c had a thinner minimal FCT (β = −6.985, P = 0.048), greater lipid index (LI) (β = 226.299, P = 0.005), and higher macrophage index (β = 54.526, P = 0.045). Even in non-diabetic patients, elevated HbA1c also linearly decreased minimal FCT (β = −14.011, P = 0.036), increased LI (β = 290.048, P = 0.041) and macrophage index (β = 120.029, P = 0.048). Subsequently, scheduled follow-ups were performed during 1-year following PCI. Multivariable linear regression analyses proved that elevated average follow-up HbA1c levels increased the VIM of lipid profiles, including low-density lipoprotein cholesterol (β = 2.594, P < 0.001), high-density lipoprotein cholesterol (β = 0.461, P = 0.044), non-high-density lipoprotein cholesterol (β = 1.473, P < 0.001), total cholesterol (β = 0.947, P < 0.001), and triglyceride (β = 4.217, P < 0.001). The result was consistent in non-diabetic patients and was verified when SD and CV were used to estimate variability.ConclusionIn patients undergoing elective PCI, elevated HbA1c increases the atherosclerotic plaque vulnerability and the visit-to-visit variability of lipid profiles, which is consistent in non-diabetic patients.

Elevated Hemoglobin A1c is Associated with Leaky Plaque Neovasculature As Detected by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Evaluation of Carotid Plaque Neovascularization in Patients with Diabetes Mellitus by Contrast-Enhanced Ultrasonography

Associations among Carotid Plaque Progression, Cerebrovascular/ Cardiovascular Diseases and LDL-C/non-HDL-C Goal Achievement in Diabetic Patients: A Retrospective Cohort Study

ELEVATION OF HEMOGLOBIN A1C INCREASE THE ATHEROSCLEROTIC PLAQUE VULNERABILITY AND THE VISIT-TO-VISIT VARIABILITY OF LIPID PROFILES IN PATIENTS WHO UNDERWENT ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

Elevated Hemoglobin A1c is Associated with Carotid Plaque Vulnerability: Novel Findings from Magnetic Resonance Imaging Study in Hypertensive Stroke Patients

Differences in Carotid Plaques Between Symptomatic Patients with and Without Diabetes Mellitus

[Change and Significance of Blood Lipids During the Course of Carotid Artery Plaque Formation Induced by Diabetes Mellitus in Patients with Ischemic Cerebral Vascular Disease].

Association of Type 2 Diabetes Mellitus and Glycemic Control with Intracranial Plaque Characteristics in Patients with Acute Ischemic Stroke.

Association of cardiovascular risk factors and intraplaque neovascularization in symptomatic carotid plaque

Relationship Between Carotid Intraplaque Neovascularization And Haemoglobin A1c In Diabetic Patients

Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study

Association of Carotid Vulnerable Atherosclerotic Plaque Features by MRI with Elevated hemoglobin A1c

Impacts of Glycemic Control on Intracranial Plaque in Patients with Type 2 Diabetes Mellitus: A Vessel Wall MRI Study

Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus with known or suspected coronary artery disease

Investigating the relationship between intracranial atherosclerotic plaque remodelling and diabetes using high-resolution vessel wall imaging

Association of Pre-Diabetes and Type 2 Diabetes Mellitus with Intracranial Plaque Characteristics in Patients with Acute Ischemic Stroke

Study on Correlation between Carotid Plaque Magnetic Resonance Imaging Characteristics and Acute Cerebral Infarction Focus Features in Patients with Diabetes Mellitus

Computed Tomography-Estimated Pancreatic Steatosis is a Risk Factor for Carotid Plaque in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

Serial Coronary Computed Tomography Angiography-Verified Coronary Plaque Progression: Comparison of Stented Patients with or Without Diabetes

Diabetes-specific Characteristics of Atherosclerotic Plaques in Femoral Arteries Determined by Three-Dimensional Magnetic Resonance Vessel Wall Imaging

Distinguishing Intracranial Diabetes-Related Atherosclerotic Plaques : A High-Resolution MRI-based Radiomics Study